XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 32.61 million as of November 7, 2025. Its market cap has decreased by -72.63% in one year.

Market Cap

32.61M

Enterprise Value

28.95M

Revenue

1.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.60

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 32.61M, a decrease of -95.95%. That is a compound annual growth rate of -14.68%.

Market Cap History

Date	Market Cap	% Change
Nov 6, 2025	32.61M	-60.00%
Dec 31, 2024	81.53M	327.50%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	91.78B
Danel (Adir Yeoshua)	2.80B
Kamada	1.25B
Bait Bakfar	1.09B
SofWave Medical	1.07B
BrainsWay	987.81M
Ilex Medical	751.17M
Novolog (Pharm-Up 1966)	623.27M

Market Cap Rankings